Brain Cancer Canada Awards an $80,000 research grant to the development of dual function therapies that harness the body's own immune system to kill brain tumour cells in glioblastomas
23 mai 2024 08h45 HE
|
Brain Cancer Canada
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce $80,000 research grant has been awarded to Dr. Peter Stirling, PhD, Associate Professor at the University of...
![Immune Network Ltd Logo](/news-release/logo/214799/0/214799.jpg?lastModified=12%2F09%2F2016%2023%3A15%3A24&size=2)
TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac Capital
30 mai 2011 10h14 HE
|
Immune Network Ltd
Agreement to fast-track introduction of new Immunoxel/Dzherelo tablet as adjunct immunotherapy, especially for MDR-TB
VANCOUVER, British Columbia, May 30, 2011 (GLOBE NEWSWIRE) -- Immune...